REFERENCES
- Haller JA, Bandello F, Belfort R Jr, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. Dec 2011;118(12):2453–2460.
- Lowder C, Belfort R Jr, Lightman S, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol. May 2011;129(5):545–553.
- Bansal R, Bansal P, Kulkarni P, Gupta V, Sharma A, Gupta A. Wandering Ozurdex®) implant. J Ophthalmic Inflamm Infect. Mar 2012;2(1):1–5.
- Vela JI, Crespi J, Andreu D. Repositioning of dexamethasone intravitreal implant (Ozurdex®) migrated into the anterior chamber. International ophthalmology. Dec 2012;32(6):583–584.
- Voykov B, Bartz-Schmidt KU. Dislocation of dexamethasone intravitreous implant. Arch Ophthalmol. Jun 2012;130(6):706.
- Cronin KM, Govind K, Kurup SK. Late migration of dexamethasone implant into anterior chamber. Arch Ophthalmol. Jun 2012;130(6):711.
- Garza-Leon M, de la Parra-Colin P. Medical treatment of crystalline lens dislocation into the anterior chamber in a patient with Marfan syndrome. International ophthalmology. Dec 2012;32(6):585–587.